Senior Counsel
Charles Lipsey, named as the 2013, 2017, and 2018 "Outstanding IP Litigator of the Year (Virginia)" at the Managing Intellectual Property Americas IP Awards, focuses his practice on intellectual property litigation, particularly patent infringement litigation.
Charles has handled cases covering a diverse spectrum of mechanical, chemical, and electrical technologies, with an emphasis on cases involving biotechnology and pharmaceutical chemistry. Since joining Finnegan in 1978, Charles has amassed a wealth of experience in patent infringement litigation, patent arbitration proceedings, and patent interferences. He is a Fellow of American College of Trial Lawyers.
The Legal 500 U.S. has recognized Charles's distinguished career over the years, naming him one of the leading lawyers in patent litigation and inducting him into the patent litigation Hall of Fame. He has also been recognized by Intellectual Asset Management as a Global Leader, a leading patent litigator in the D.C. area, and for his practice before the Federal Circuit.
Charles was also inducted into LMG Life Sciences' Hall of Fame, and recognized as "Hatch-Waxman (Branded) Litigator of the Year," at the LMG Life Sciences Awards in 2013 and again in 2018. He furthermore has been honored for his contributions in the fields of "General Patent Litigation" and "Hatch-Waxman (Branded) Patent Litigation" by the same legal ranking directory. Charles has been ranked among top U.S. patent lawyers in Legal Media Group's Guide to the Worlds Leading Patent Law Practitioners since 2011. World IP Review recognized him as a WIPR Leader for patents in the United States and Benchmark Litigation named him a litigation star.
Appellate counsel for Valeant and Salix, successfully argued motion to disqualify opposing counsel at Federal Circuit.
18-2097, Fed. Cir., Judges Lourie, O'Malley, Reyna
1:08-cv-01547, S.D. Ind., Judges Baker, Lawrence, Pratt
2:10-cv-06908, E.D. Pa., Judges Angell, Savage, Cohen (Special Master)
13-1544, 16-2647, Fed. Cir., Judges Hughes, Lourie, Moore, Newman, Plager
1:05-cv-00336, -00337, D. Del., Judge Robinson
00-1487, Fed. Cir., Judges Mayer, Newman, Michel
1:91-cv-05056, E.D.N.Y., Judge Rader (Visiting Judge)
1:06-cv-01017, S.D. Ind., Judges Barker, Magnus-Stinson
09-1071; 10-1005, -1033, Fed. Cir., Judges Linn, Michel, Prost, Rader
1:18-cv-00664, D. Del., Judge Andrews
1:14-cv-00664, D. Del., Judge Sleet
IPR2015-01340, PTAB, Judges Elluru, Paulraj, Tierney
Defended MedImmune, LLC in patent infringement litigation brought by Novartis Vaccines and Diagnostics, Inc. concerning recombinant DNA expression vectors; case ultimately resolved through confidential settlement.
1:11-cv-00084, D. Del., Judges Robinson, Thynge
Successfully represented DuPont in an appeal involving the written description requirement under 35 U.S.C § 112. JMOL in favor of DuPont sustained on appeal.
12-1433, Fed. Cir., Judges Rader, Schall, Bryson
1:10-md-02200, D. Del., Judge Sleet
10-1500, -1520, -1521, -1522, -1523, -1524, Fed. Cir., Judges Lourie, Newman
2:07-cv-03770, D.N.J., Judges Cavanaugh, Dickson, Falk
1:08-md-01949, D. Del., Judges Farnan, Stark
10-1460, -1461, -1462, -1463, -1464, -1465, -1466, -1467, -1468, -1469, -1470, -1471, -1472, -1473, Fed. Cir., Judges Mayer, Newman, Plager
1:06-cv-00238, S.D. Ind., Judges Barker, McVicker Lynch, Magnus-Stinson
1:02-cv-11280, D. Mass., Judge Zobel
08-1248, Fed. Cir., Judges Bryson, Dyk, Gajarsa, Linn, Lourie, Mayer, Michel, Moore, Newman, Prost, Rader
1:01-cv-00443, S.D. Ind., Judges LaRue, Lynch, Shields, Young
05-1429, -1430, Fed. Cir., Judges Rader, Schall, Gajarsa
3:90-cv-00373, N.D. Cal., Judge Jensen
91-ml-912, S.D. Ind., Judges Dillin, Brazil
92-cv-00224, S.D. Ind., Judges Dillin, Godich
96-1175, Fed. Cir., Judges Newman, Lourie, Bryson
92-cv-00224, S.D. Ind., Judges Dillin, Godich
96-1175, Fed. Cir., Judges Newman, Lourie, Bryson
87-1346, S. Ct., Judges O'Connor, Renquist, Brennan, White, Marshall, Stevens, Scalia, Kennedy
Valeant Pharmaceuticals International, Inc. v. Mylan Pharmaceuticals Inc.
Appellate counsel for Valeant and Salix, successfully argued motion to disqualify opposing counsel at Federal Circuit.
18-2097, Fed. Cir., Judges Lourie, O'Malley, Reyna
Eli Lilly & Co. v. Wockhardt Ltd.
Lead counsel for Lilly in Hatch-Waxman patent infringement litigations against several ANDA filers seeking FDA approval to market generic versions of Eli Lilly's Cymbalta®. The S.D. Indiana entered judgment before trial in favor of Eli Lilly and against all the ANDA filers on all issues, resulting in orders and judgment maintaining Cymbalta's® market exclusivity through the end of its patent life.
1:08-cv-01547, S.D. Ind., Judges Baker, Lawrence, Pratt
Alzheimer's Institute of America, Inc. v. Avid Radiopharmaceuticals
Lead trial counsel for Avid in suit concerning amyloid beta technology and its use in animal models in searching for drugs to treat Alzheimer's disease (AD). Obtained jury verdict for Avid on issue of inventorship and patent ownership in 2012; affirmed by the Federal Circuit in 2013. Also obtained a finding of exceptional case, entitling Avid to an award of attorneys' fees. The trial disposed of a series of suits by the AIA against numerous companies involved in scientific research relating to Alzheimer's disease.
2:10-cv-06908, E.D. Pa., Judges Angell, Savage, Cohen (Special Master)
13-1544, 16-2647, Fed. Cir., Judges Hughes, Lourie, Moore, Newman, Plager
Astellas Pharma U.S., Inc. v. Sicor, Inc.
Lead trial counsel for Astellas in action to prevent generic competition in pharmacological heart stress agent Adenoscan®. Tried and settled favorably to patent holder after trial.
1:05-cv-00336, -00337, D. Del., Judge Robinson
Loral Fairchild Corp. v. Sony Corp.
Lead trial counsel (on equitable defenses) and appellate counsel for Sony in action for infringement of patent covering camcorder imaging devices. Adverse jury verdict overturned on post-trial motion for judgment as a matter of law, sustained on appeal.
00-1487, Fed. Cir., Judges Mayer, Newman, Michel
1:91-cv-05056, E.D.N.Y., Judge Rader (Visiting Judge)
Eli Lilly and Company v. Teva Pharmaceuticals USA, Inc.
Lead trial and appellate counsel for Eli Lilly in district court and Federal Circuit in action to prevent generic competition with respect to osteoporosis drug Evista®. Two of three patent families in suit found valid and infringed.
1:06-cv-01017, S.D. Ind., Judges Barker, Magnus-Stinson
09-1071; 10-1005, -1033, Fed. Cir., Judges Linn, Michel, Prost, Rader
Articles
Inter Partes Review in Generic Drug Litigation—Why the USPTO Should Exercise Its Discretion to Deny IPR Petitions in Appropriate Hatch-Waxman Act Disputes Inter Partes Review in Generic Drug Litigation—Why the USPTO Should Exercise Its Discretion to Deny IPR Petitions in Appropriate Hatch-Waxman Act Disputes
March 7, 2014
pharmaphorumEvent
ANDA Workshop: Strategies and Insights for Branded Pharmaceutical Companies ANDA Workshop: Strategies and Insights for Branded Pharmaceutical Companies
February 4, 2014
Boston
Event
ANDA Workshop: Strategies and Insights For Branded Pharmaceutical Companies ANDA Workshop: Strategies and Insights For Branded Pharmaceutical Companies
October 17, 2013
Palo Alto
"Lipsey is well versed in handling patent litigation in several industries, but in the past year he… led his patron to a major victory that ensured seven years of patent exclusivity on a high-value product."
Intellectual Asset Management Patent 1000
“Another jewel in the crown of the contentious division is the life sciences patent litigation offering spearheaded by Charles Lipsey.”
Intellectual Asset Management Patent 1000
“Charles is phenomenal – he is really smart on the science, hugely experienced and has a nice style in court.”
Intellectual Asset Management Patent 1000
“One of the line-up’s most famous representatives is ‘wonderful lawyer’ Charles Lipsey, ‘an excellent lead in big pharmaceutical cases’ and ‘formidable opponent but also a gentleman who plays by the rules.’”
Intellectual Asset Management Patent 1000
“In the Northern Virginia office are some of Finnegan’s top legal talents, including Charles Lipsey, who heads much of the practice's high-stakes patent litigations.”
Managing Intellectual Property’s IP Stars
“Charles Lipsey is one of the leading trial lawyers in Finnegan's patent group, contributing decades of experience in IP and a specialty in handling cases related to life sciences technology.”
Managing Intellectual Property’s IP Stars
“Lipsey shines brilliantly in life sciences patent litigation.”
Intellectual Asset Management Patent 1000
“The ‘terrific’ Charles Lipsey has a wealth of experience handling patent infringement litigation. He frequently represents companies in the life sciences sector.”
Chambers USA
“Charles Lipsey acts for pharmaceutical and biotechnology companies in complex patent litigation, including appellate and PTAB proceedings. Clients say: ‘He is near the top of the list when you have a massive case and need someone superlative.’”
Chambers USA
“Sources note that Charles Lipsey is ‘well respected’ and experienced in the courtroom. He is a seasoned litigator with noted knowledge of the biotechnology and pharmaceutical industries.”
Chambers Global
“Attorney Charles Lipsey is praised as an especially smart and reliable attorney with a depth of insight about pharmaceutical technology…he is among the country’s top names representing brand name pharmaceutical companies.”
Managing Intellectual Property’s IP Stars
“One peer regards Charles Lipsey as a ‘top notch life science litigator.’”
Managing Intellectual Property’s IP Stars
“Charles Lipsey focuses his practice on patent infringement litigation. A Peer calls him a ‘leader’ and ‘always good.’”
Managing Intellectual Property’s IP Stars
“On the patent contentious front, Reston-based Charles Lipsey manages a diverse practice which focuses on mechanical, electrical, and chemical technologies.”
Managing Intellectual Property’s IP Stars
“…[T]his…client representative identified Charles Lipsey as ‘a very smart and reliable attorney.’”
LMG Life Sciences
“…[B]iotechnology and pharmaceutical doyen Charles Lipsey [is a] top name at the Federal Circuit…”
Intellectual Asset Management Patent 1000
“Charles Lipsey, a doyen of the biotechnology and pharmaceutical patent litigation arenas…”
Intellectual Asset Management Patent 1000
“Charlie Lipsey offers a wealth of experience in patent infringement lawsuits, particularly within the pharmaceutical field.”
Chambers Global
“Charlie Lipsey is ‘a fabulous lawyer and a top guy.’ He… is an expert in IP and patent infringement litigation.”
Chambers USA
“During the research process for IP Stars, attorney Charles Lipsey consistently received the most mentions among his peers in Virginia and, partly as a result, was named Managing IP’s…Virginia ‘Litigator of the Year…’ Lipsey is among the country’s top names representing brand name pharmaceutical companies.”
Managing Intellectual Property’s IP Stars
“Sources characterize Charlie Lipsey as being ‘excellent—a very good patent attorney.’ He enjoys an enviable reputation for his litigation-centered practice, receiving significant acclaim for his adroit handling of patent infringement cases.”
Chambers Global and Chambers USA
“Charlie Lipsey has a diverse practice with a particular focus on biotechnology and pharmaceutical chemistry. Sources describe him as ‘a fabulous lawyer in patent litigation.’”
Chambers USA
“Charlie Lipsey is an efficient and well-recognized patent litigator, and specializes in representing biotechnology and pharmaceutical clients. He is frequently commended by sources as a ‘notable litigator.’”
Chambers USA
“Charlie Lipsey is regarded by clients as ‘one of the preeminent trial attorneys for Hatch-Waxman cases.’ He is a partner in the Reston office and focuses primarily on IP litigation, with special concentration on patent infringement litigation.”
Chambers USA
“‘Very strong practitioner’ Charles Lipsey concentrates his practice on the representation of clients in patent infringement litigation. He is particularly well versed in handling matters on behalf of chemistry, biotechnology and pharmaceutical companies.”
Chambers Global and Chambers USA
“‘Skilled patent trial lawyer’ Charles Lipsey earns ‘a great deal of respect’ from peers for his representation of innovator clients in Hatch-Waxman litigation. Sources are quick to point out his effective advocacy style, reporting: ‘He is an excellent lawyer. He's is great in court and is a pleasure to work with.’”
Chambers USA
“Sources note that Charles Lipsey is ‘well respected’ and experienced in the courtroom. He is a seasoned litigator with noted knowledge of the biotechnology and pharmaceutical industries.”
Chambers USA
“Charles Lipsey is a ‘highly respected’ litigator who is recommended representation for federal circuit appellate cases. He is adept counsel for complex patent disputes and is distinguished for his recent experience handling Hatch-Waxman proceedings.”
Chambers USA
“Charles Lipsey stands out as one of the leaders in the group, who after 40 years at the firm has established himself as one of the country’s foremost patent litigators.”
Managing Intellectual Property’s IP Stars
“(…) Lipsey (…) continues to stand out as an elevated strategic thinker and devastatingly effective courtroom lawyer. He has handled a vast number of Hatch-Waxman cases.”
Intellectual Asset Management Patent 1000
"Lipsey is well versed in handling patent litigation in several industries, but in the past year he… led his patron to a major victory that ensured seven years of patent exclusivity on a high-value product."
Intellectual Asset Management Patent 1000
“Another jewel in the crown of the contentious division is the life sciences patent litigation offering spearheaded by Charles Lipsey.”
Intellectual Asset Management Patent 1000
“Charles is phenomenal – he is really smart on the science, hugely experienced and has a nice style in court.”
Intellectual Asset Management Patent 1000
“One of the line-up’s most famous representatives is ‘wonderful lawyer’ Charles Lipsey, ‘an excellent lead in big pharmaceutical cases’ and ‘formidable opponent but also a gentleman who plays by the rules.’”
Intellectual Asset Management Patent 1000
“In the Northern Virginia office are some of Finnegan’s top legal talents, including Charles Lipsey, who heads much of the practice's high-stakes patent litigations.”
Managing Intellectual Property’s IP Stars
“Charles Lipsey is one of the leading trial lawyers in Finnegan's patent group, contributing decades of experience in IP and a specialty in handling cases related to life sciences technology.”
Managing Intellectual Property’s IP Stars
“Lipsey shines brilliantly in life sciences patent litigation.”
Intellectual Asset Management Patent 1000
“The ‘terrific’ Charles Lipsey has a wealth of experience handling patent infringement litigation. He frequently represents companies in the life sciences sector.”
Chambers USA
“Charles Lipsey acts for pharmaceutical and biotechnology companies in complex patent litigation, including appellate and PTAB proceedings. Clients say: ‘He is near the top of the list when you have a massive case and need someone superlative.’”
Chambers USA
“Sources note that Charles Lipsey is ‘well respected’ and experienced in the courtroom. He is a seasoned litigator with noted knowledge of the biotechnology and pharmaceutical industries.”
Chambers Global
“Attorney Charles Lipsey is praised as an especially smart and reliable attorney with a depth of insight about pharmaceutical technology…he is among the country’s top names representing brand name pharmaceutical companies.”
Managing Intellectual Property’s IP Stars
“One peer regards Charles Lipsey as a ‘top notch life science litigator.’”
Managing Intellectual Property’s IP Stars
“Charles Lipsey focuses his practice on patent infringement litigation. A Peer calls him a ‘leader’ and ‘always good.’”
Managing Intellectual Property’s IP Stars
“On the patent contentious front, Reston-based Charles Lipsey manages a diverse practice which focuses on mechanical, electrical, and chemical technologies.”
Managing Intellectual Property’s IP Stars
“…[T]his…client representative identified Charles Lipsey as ‘a very smart and reliable attorney.’”
LMG Life Sciences
“…[B]iotechnology and pharmaceutical doyen Charles Lipsey [is a] top name at the Federal Circuit…”
Intellectual Asset Management Patent 1000
“Charles Lipsey, a doyen of the biotechnology and pharmaceutical patent litigation arenas…”
Intellectual Asset Management Patent 1000
“Charlie Lipsey offers a wealth of experience in patent infringement lawsuits, particularly within the pharmaceutical field.”
Chambers Global
“Charlie Lipsey is ‘a fabulous lawyer and a top guy.’ He… is an expert in IP and patent infringement litigation.”
Chambers USA
“During the research process for IP Stars, attorney Charles Lipsey consistently received the most mentions among his peers in Virginia and, partly as a result, was named Managing IP’s…Virginia ‘Litigator of the Year…’ Lipsey is among the country’s top names representing brand name pharmaceutical companies.”
Managing Intellectual Property’s IP Stars
“Sources characterize Charlie Lipsey as being ‘excellent—a very good patent attorney.’ He enjoys an enviable reputation for his litigation-centered practice, receiving significant acclaim for his adroit handling of patent infringement cases.”
Chambers Global and Chambers USA
“Charlie Lipsey has a diverse practice with a particular focus on biotechnology and pharmaceutical chemistry. Sources describe him as ‘a fabulous lawyer in patent litigation.’”
Chambers USA
“Charlie Lipsey is an efficient and well-recognized patent litigator, and specializes in representing biotechnology and pharmaceutical clients. He is frequently commended by sources as a ‘notable litigator.’”
Chambers USA
“Charlie Lipsey is regarded by clients as ‘one of the preeminent trial attorneys for Hatch-Waxman cases.’ He is a partner in the Reston office and focuses primarily on IP litigation, with special concentration on patent infringement litigation.”
Chambers USA
“‘Very strong practitioner’ Charles Lipsey concentrates his practice on the representation of clients in patent infringement litigation. He is particularly well versed in handling matters on behalf of chemistry, biotechnology and pharmaceutical companies.”
Chambers Global and Chambers USA
“‘Skilled patent trial lawyer’ Charles Lipsey earns ‘a great deal of respect’ from peers for his representation of innovator clients in Hatch-Waxman litigation. Sources are quick to point out his effective advocacy style, reporting: ‘He is an excellent lawyer. He's is great in court and is a pleasure to work with.’”
Chambers USA
“Sources note that Charles Lipsey is ‘well respected’ and experienced in the courtroom. He is a seasoned litigator with noted knowledge of the biotechnology and pharmaceutical industries.”
Chambers USA
“Charles Lipsey is a ‘highly respected’ litigator who is recommended representation for federal circuit appellate cases. He is adept counsel for complex patent disputes and is distinguished for his recent experience handling Hatch-Waxman proceedings.”
Chambers USA
“Charles Lipsey stands out as one of the leaders in the group, who after 40 years at the firm has established himself as one of the country’s foremost patent litigators.”
Managing Intellectual Property’s IP Stars
“(…) Lipsey (…) continues to stand out as an elevated strategic thinker and devastatingly effective courtroom lawyer. He has handled a vast number of Hatch-Waxman cases.”
Intellectual Asset Management Patent 1000
Award/Ranking
31 Finnegan Attorneys Recognized by Best Lawyers 31 Finnegan Attorneys Recognized by Best Lawyers
August 15, 2024
Best LawyersAward/Ranking
Finnegan Ranks at the Top of the Managing Intellectual Property IP Stars Rankings Finnegan Ranks at the Top of the Managing Intellectual Property IP Stars Rankings
June 28, 2024
Managing Intellectual PropertyAward/Ranking
46 Finnegan Attorneys Ranked in 2024 IAM Patent 1000 46 Finnegan Attorneys Ranked in 2024 IAM Patent 1000
June 6, 2024
Intellectual Asset ManagementAward/Ranking
Seven Finnegan Partners Named IAM Global Leaders for 2024 Seven Finnegan Partners Named IAM Global Leaders for 2024
November 14, 2023
IAMAward/Ranking
Five Finnegan Partners Named 2024 Leading Litigators in America by Lawdragon Five Finnegan Partners Named 2024 Leading Litigators in America by Lawdragon
October 30, 2023
The Lawdragon 500: Leading Litigators in AmericaAward/Ranking
Finnegan Receives Tier 1 Benchmark Litigation Rankings; Nine Attorneys Named Litigation Stars Finnegan Receives Tier 1 Benchmark Litigation Rankings; Nine Attorneys Named Litigation Stars
October 5, 2023
Benchmark LitigationDue to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.